Omalizumab mitigates anaphylaxis during ultrarush honey bee venom immunotherapy in monoclonal mast cell activation syndrome

被引：35
|
作者：
da Silva, Elizabeth Nicole [1 ,2 ]
Randall, Katrina Louise [1 ,2 ]
机构：
[1] Canberra Hosp, Dept Immunol, Canberra, ACT, Australia
[2] Australian Natl Univ, Sch Med, Canberra, ACT, Australia
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE | 2013年 / 1卷 / 06期
关键词：
D O I：
10.1016/j.jaip.2013.07.004
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：687 / 688
页数：2
相关论文
共 50 条
  • [1] CONCURRENT DOSING WITH OMALIZUMAB MITIGATES ANAPHYLAXIS DURING ULTRA-RUSH HONEY BEE VENOM IMMUNOTHERAPY IN MONOCLONAL MAST CELL ACTIVATION SYNDROME
    da Silva, Elizabeth
    Choe, Renee
    Field, Elise
    Wilson, Anastasia
    Randall, Katrina
    INTERNAL MEDICINE JOURNAL, 2012, 42 : 17 - 17
  • [2] A CASE OF RECURRENT ANAPHYLAXIS TO HONEY BEE VENOM IMMUNOTHERAPY WITH OMALIZUMAB USED AS A PREMEDICATION
    Williams, Terri
    McGettigan, Ben
    Ganeshanandan, Luckshman
    O'Sullivan, Michael
    INTERNAL MEDICINE JOURNAL, 2018, 48 : 18 - 18
  • [3] Omalizumab For a Case Of Monoclonal Mast Cell Activation Syndrome With Recurrent Anaphylaxis
    Jagdis, Amanda
    Vadas, Peter
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB27 - AB27
  • [4] Omalizumab in prevention of anaphylaxis due to bee venom immunotherapy
    Lopes, J. B.
    Barreira, P.
    Moreira Da Silva, J. P.
    ALLERGY, 2017, 72 : 683 - 684
  • [5] Successful treatment of refractory anaphylaxis using omalizumab in monoclonal mast cell activation syndrome
    O'Keefe, A.
    ALLERGY, 2018, 73 : 466 - 466
  • [6] Efficacy of pretreatment with omalizumab in severe anaphylaxis to bee venom immunotherapy
    Lobera, T.
    Escudero, R.
    Del Pozo, M.
    Blasco, A.
    Gonzalez Mahave, I
    ALLERGY, 2011, 66 : 438 - 438
  • [7] Omalizumab effectively prevents recurrent refractory anaphylaxis in patient with monoclonal mast cell activation syndrome
    Jagdis, Amanda
    Vadas, Peter
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2014, 113 (01) : 115 - 116
  • [8] Omalizumab pretreatment prior to bee venom immunotherapy in patients with previous anaphylaxis to immunotherapy
    Alba, P.
    Calderon, R.
    Frechina, C.
    Alvarino, M.
    ALLERGY, 2012, 67 : 404 - 404
  • [9] IDIOPATHIC ANAPHYLAXIS, MAST CELL ACTIVATION SYNDROME CONTROLLED WITH OMALIZUMAB
    Chen, M.
    Kim, A.
    Christiansen, S.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S30 - S31
  • [10] Idiopathic mast cell activation disorder: control of idiopathic and venom immunotherapy associated anaphylaxis with low dose Omalizumab
    Berry, R.
    Hollingsworth, P.
    Lucas, M.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 1209 - 1209
12345